One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial

IMPORTANCE: In patients with heart failure (HF) and left ventricular ejection fraction (LVEF) equal to or greater than 40%, a transcatheter interatrial shunt device (IASD; Corvia Medical) reduces exercise pulmonary capillary wedge pressure (PCWP) and is safe compared with sham control treatment at 1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Shah, Sanjiv J., Feldman, Ted, Ricciardi, Mark J., Kahwash, Rami, Lilly, Scott, Litwin, Sheldon, Nielsen, Chris D., van der Harst, Pim, Hoendermis, Elke, Penicka, Martin, Bartunek, Jozef, Fail, Peter S., Kaye, David M., Walton, Anthony, Petrie, Mark C., Walker, Niki, Basuray, Anupam, Yakubov, Steven, Hummel, Scott L., Chetcuti, Stanley, Forde-McLean, Rhondalyn, Herrmann, Howard C., Burkhoff, Daniel, Massaro, Joseph M., Cleland, John G. F., Mauri, Laura
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2018
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233816/
https://ncbi.nlm.nih.gov/pubmed/30167646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2018.2936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados